未登录

J

Jason T. Yustein

Emory University

H指数:34

被引数:5,178

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Role of MYC in Tumor Immune Microenvironment Regulation: Insights and Future Directions

MYC在肿瘤免疫微环境调控中的作用：见解与未来方向

FRONTIERS IN BIOSCIENCE-LANDMARK

IF3.1

2025-09-230

OAAI

Central memory-enriched Vγ9Vδ2 γδ T cells via TGF-β expansion demonstrate enhanced in vivo efficacy against metastatic osteosarcoma

通过TGF-β扩增的中央记忆富集的Vγ9Vδ2 γδ T细胞显示出对转移性骨肉瘤的体内增强疗效

Frontiers in Immunology

IF5.9

2025-09-030

OA

FGF8 promotes non-canonical KRAS/MAPK pathway in favorable histology Wilms' tumor

CANCER RESEARCH

IF16.6

2024-09-050

PRE

Preclinical models for the study of pediatric solid tumors: focus on bone sarcomas

FRONTIERS IN ONCOLOGY

IF3.3

2024-07-181

OAAI

Intrinsic Epigenetic State of Primary Osteosarcoma Drives Metastasis

MOLECULAR CANCER RESEARCH

IF4.7

2024-06-060

OA

Leukocyte-based biomimetic nanoparticles for combined targeted and immunotherapy in osteosarcoma

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Systemic Cisplatin Does Not Affect the Bone Regeneration Process in a Critical Size Defect Murine Model

ACS BIOMATERIALS SCIENCE & ENGINEERING

IF5.5

2024-02-130

PRE

MYC regulates CSF1 expression via microRNA 17/20a to modulate tumor- associated macrophages in osteosarcoma

MYC通过microRNA 17/20a调节CSF1表达调控骨肉瘤中肿瘤相关巨噬细胞

IF6.1

2023-07-1013

OA

Toward quantification of hypoxia using fluorinated EuII/III-containing ratiometric probes

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2023-04-056

OAAI

Myc-regulated miR17, 20a modulate RANK expression in osteosarcoma

CANCER RESEARCH

IF16.6

2023-04-042

PRE

B7-H3-CAR T-cell therapy in immune-competent osteosarcoma models: Regnase-1 KO overcomes limited CAR T-cell expansion

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Poly(ADP-ribose) polymerase 1 and Ste20-like kinase hKFC act as transcriptional repressors for gamma-2 herpesvirus lytic replication

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-2781

OAAI

Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-27564

OAAI

Osteogenesis in the presence of chemotherapy: A biomimetic approach

JOURNAL OF TISSUE ENGINEERING

IF7

2022-11-252

OAAI

LncRNA PVT-1 promotes osteosarcoma cancer stem-like properties through direct interaction with TRIM28 and TSC2 ubiquitination

LncRNA PVT-1通过与TRIM28和TSC2泛素化的直接相互作用促进骨肉瘤癌症干细胞样特性

IF7.3

2022-11-0812

OA

An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma

NPJ PRECISION ONCOLOGY

IF8

2022-09-1722

OAAI

Shulman, David S.; Whittle, Sarah B.; Surdez, Didier; Bailey, Kelly M.; de Alava, Enrique; Yustein, Jason T.; Shlien, Adam; Hayashi, Masanori; Bishop, Alexander J. R.; Crompton, Brian D.; DuBois, Steven G.; Shukla, Neerav; Leavey, Patrick J.; Lessnick, Stephen L.; Kovar, Heinrich; Delattre, Olivier; Gruenewald, Thomas G. P.; Antonescu, Cristina R.; Roberts, Ryan D.; Toretsky, Jeffrey A.; Tirode, Franck; Gorlick, Richard; Janeway, Katherine A.; Reed, Damon; Lawlor, Elizabeth R.; Grohar, Patrick J.

Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2022-04-1122

OAAI

K-Ras and p53 mouse model with molecular characteristics of human rhabdomyosarcoma and translational applications

DISEASE MODELS & MECHANISMS

IF3.3

2022-02-1712

OAAI

Nanodelivery Systems Face Challenges and Limitations in Bone Diseases Management

ADVANCED THERAPEUTICS

IF2.6

2021-10-1811

OAAI

Upregulation of miR181a/miR212 Improves Myogenic Commitment in Murine Fusion-Negative Rhabdomyosarcoma

FRONTIERS IN PHYSIOLOGY

IF3.4

2021-08-069

OAAI